iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionSlateStone Wealth, LLC
Latest Disclosed Ownership2,680 shares
Latest Disclosed Value $ 453
SlateStone Wealth, LLC reports 10.07% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - SlateStone Wealth, LLC filed a 13F-HR form disclosing ownership of 2,680 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $453 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,980 shares of iShares Trust - iShares Biotechnology ETF. The current value of the position is $351,214 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F iShares NASDAQ Biotech ETF 464287556 2,680 -300 -10.07 0 0.0373
2026-02-11 2025-12-31 13F iShares NASDAQ Biotech ETF 464287556 2,980 -440 -12.87 1 0.0421
2025-11-05 2025-09-30 13F iShares NASDAQ Biotech ETF 464287556 3,420 -2,370 -40.93 0 0.0428
2025-08-12 2025-06-30 13F iShares NASDAQ Biotech ETF 464287556 5,790 -120 -2.03 1 0.0684
2025-05-08 2025-03-31 13F iShares NASDAQ Biotech ETF 464287556 5,910 -390 -6.19 1 0.0759
2025-02-10 2024-12-31 13F iShares NASDAQ Biotech ETF 464287556 6,300 -15,241 -70.75 1 -100.00 0.0817
2024-11-07 2024-09-30 13F iShares NASDAQ Biotech ETF 464287556 21,541 -170 -0.78 3 50.00 0.2824
2024-07-25 2024-06-30 13F iShares NASDAQ Biotech ETF 464287556 21,711 -500 -2.25 3 -33.33 0.3229
2024-04-26 2024-03-31 13F iShares NASDAQ Biotech ETF 464287556 22,211 -4,145 -15.73 3 0.00 0.3061
2024-02-01 2023-12-31 13F iShares NASDAQ Biotech ETF 464287556 26,356 906 3.56 4 0.00 0.4646
2023-10-12 2023-09-30 13F iShares NASDAQ Biotech ETF 464287556 25,450 -1,000 -3.78 3 0.00 0.4526
2023-08-07 2023-06-30 13F iShares NASDAQ Biotech ETF 464287556 26,450 885 3.46 3 0.00 0.6292
2023-08-08 2023-03-31 13F iShares NASDAQ Biotech ETF 464287556 25,565 0 0.00 3 -99.91 0.6838
2023-02-01 2022-12-31 13F iShares NASDAQ Biotech ETF 464287556 25,565 0 0.00 3,356 12.24 0.8097
2022-11-03 2022-09-30 13F iShares NASDAQ Biotech ETF 464287556 25,565 -50 -0.20 2,990 -0.76 0.7956
2022-08-04 2022-06-30 13F iShares NASDAQ Biotech ETF 464287556 25,615 0 0.00 3,013 -9.74 0.7697
2022-05-04 2022-03-31 13F iShares NASDAQ Biotech ETF 464287556 25,615 -710 -2.70 3,338 -16.92 0.7443
2022-02-02 2021-12-31 13F iShares NASDAQ Biotech ETF 464287556 26,325 1,050 4.15 4,018 -1.66 0.8584
2021-10-28 2021-09-30 13F iShares NASDAQ Biotech ETF 464287556 25,275 0 0.00 4,086 -1.21 0.9355
2021-08-02 2021-06-30 13F iShares NASDAQ Biotech ETF 464287556 25,275 0 0.00 4,136 8.70 0.9456
2021-04-19 2021-03-31 13F iShares NASDAQ Biotech ETF 464287556 25,275 -150 -0.59 3,805 -1.22 0.9401
2021-01-25 2020-12-31 13F iShares NASDAQ Biotech ETF 464287556 25,425 -155 -0.61 3,852 11.20 0.9606
2020-10-27 2020-09-30 13F iShares NASDAQ Biotech ETF 464287556 25,580 0 0.00 3,464 -0.94 0.7477
2020-07-29 2020-06-30 13F iShares NASDAQ Biotech ETF 464287556 25,580 530 2.12 3,497 29.57 0.7817
2020-04-28 2020-03-31 13F iShares NASDAQ Biotech ETF 464287556 25,050 -300 -1.18 2,699 -11.65 0.7677
2020-02-06 2019-12-31 13F iShares NASDAQ Biotech ETF 464287556 25,350 -525 -2.03 3,055 18.64 0.6986
2019-11-05 2019-09-30 13F iShares NASDAQ Biotech ETF 464287556 25,875 -2,050 -7.34 2,575 -15.49 0.7518
2019-08-05 2019-06-30 13F iShares NASDAQ Biotech ETF 464287556 27,925 -6,000 -17.69 3,047 -19.67 0.8581
2019-05-06 2019-03-31 13F iShares NASDAQ Biotech ETF 464287556 33,925 0 0.00 3,793 15.96 1.1648
2019-02-13 2018-12-31 13F iShares NASDAQ Biotech ETF 464287556 33,925 33,925 3,271 1.5042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.